IRS Guidance Regarding Qualifying Therapeutic Discovery Project Credit


On May 21, 2010, the Internal Revenue Service released Notice 2010-45,1 which provides anticipated guidance regarding the filing of claims for a qualifying therapeutic discovery project (“QTDP”) credit. The QTDP credit is a refundable tax credit established by the recently passed Patient Protection and Affordable Care Act, and is directed at companies with not more than 250 employees that have expended money on certain biotechnology research projects.

Pryor Cashman Tax Partner Michael Dunworth and Counsel Martin Jones have written an informative Legal Update, entitled IRS Guidance Regarding Qualifying Therapeutic Discovery Project Credit, summarizing the highlights of Notice 2010-45.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Pryor Cashman LLP | Attorney Advertising

Written by:


Pryor Cashman LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.